QSI peer analysis
Quantum-Si (QSI) against its competitors: price, today's move, 1-year return and market value side by side.
QSI and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADCT ADC Therapeutics | $1.53 | -6.71% | -60.50% | $201.71M |
| ALT Altimmune | $2.07 | 5.08% | -44.27% | $406.54M |
| ANNX Annexon | $4.20 | 4.87% | 39.37% | – |
| AURA Aura Biosciences | $6.56 | 3.47% | 20.68% | – |
| AUTL Autolus Therapeutics | $1.30 | 3.17% | -7.22% | $342.02M |
| DBVT DBV Technologies | $10.45 | 6.63% | -25.71% | $658.64M |
| ENGN enGene Therapeutics | $1.75 | 4.17% | -72.40% | – |
| LBRX LB Pharmaceuticals | $42.50 | 11.58% | 158.95% | – |
| RCKT Rocket Pharmaceuticals | $2.39 | -1.89% | -28.16% | $261.81M |
| SLDB Solid Biosciences | $6.72 | 8.74% | 67.43% | $705.54M |
| QSI Quantum-Si | $1.32 | 12.85% | -26.67% | – |
- QSI's peers: ADCT (ADC Therapeutics), ALT (Altimmune), ANNX (Annexon), AURA (Aura Biosciences), AUTL (Autolus Therapeutics), DBVT (DBV Technologies), ENGN (enGene Therapeutics), LBRX (LB Pharmaceuticals).
Updated 2026-11-07 11:56 UTC